Definitions and diagnosis of pulmonary hypertension

Journal of the American College of Cardiology

Volumn 62, Issue 25 SUPPL., 2013, Pages

  Hoeper, Marius M ^a   Bogaard, Harm Jan ^b   Condliffe, Robin ^c   Frantz, Robert ^d   Khanna, Dinesh ^e   Kurzyna, Marcin ^f   Langleben, David ^g   Manes, Alessandra ^h   Satoh, Toru ⁱ   Torres, Fernando ^j   Wilkins, Martin R ^k   Badesch, David B ^l  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^f Centre of Postgraduate Urology Education   (Poland)

^g MCGILL UNIVERSITY   (Canada)

^h UNIVERSITY OF BOLOGNA   (Italy)

ⁱ KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j UNIVERSITY OF TEXAS AT DALLAS   (United States)

^k IMPERIAL COLLEGE LONDON   (United Kingdom)

^l UNIVERSITY OF COLORADO   (United States)

more..

Author keywords

diagnosis; hemodynamics; pulmonary hypertension; right heart catheterization; screening

Indexed keywords

CARBON MONOXIDE;

CLINICAL ASSESSMENT; CONFERENCE PAPER; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HIGH RISK POPULATION; HUMAN; LUNG ARTERY PRESSURE; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; LUNG VASCULAR RESISTANCE; LUNG WEDGE PRESSURE; POSITIVE END EXPIRATORY PRESSURE; PREDICTIVE VALUE; PRESSURE TRANSDUCER; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; SYSTEMIC SCLEROSIS;

CARDIAC OUTPUT; CO; CONNECTIVE TISSUE DISEASE; CTD; DIAGNOSIS; DIFFUSION CAPACITY FOR CARBON MONOXIDE; DLCO; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEMODYNAMICS; HERITABLE PULMONARY ARTERIAL HYPERTENSION; HFPEF; HPAH; IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION; IPAH; LEFT VENTRICULAR END-DIASTOLIC PRESSURE; LVEDP; MEAN PULMONARY ARTERY PRESSURE; N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE; NT-PROBNP; PAH; PAPM; PAWP; PH; PULMONARY ARTERIAL HYPERTENSION; PULMONARY ARTERY WEDGE PRESSURE; PULMONARY HYPERTENSION; PULMONARY VASCULAR RESISTANCE; PVR; RHC; RIGHT HEART CATHETERIZATION; SCLERODERMA; SCREENING; SSC; WOOD UNITS; WU;

ANIMALS; HUMANS; HYPERTENSION, PULMONARY; PRACTICE GUIDELINES AS TOPIC;

EID: 84890776626     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.10.032     Document Type: Conference Paper

References (54)

1. D.B. Badesch, H.C. Champion, and M.A. Sanchez Diagnosis and assessment of pulmonary arterial hypertension J Am Coll Cardiol 54 2009 S55 S66
2. N. Galie, M.M. Hoeper, and M. Humbert Guidelines for the diagnosis and treatment of pulmonary hypertension. The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Respir J 34 2009 1219 1263
3. V.V. McLaughlin, S.L. Archer, and D.B. Badesch ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association J Am Coll Cardiol 53 2009 1573 1619
4. N. Galie, M.M. Hoeper, and M. Humbert Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Heart J 30 2009 2493 2537
5. G. Kovacs, A. Berghold, S. Scheidl, and H. Olschewski Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review Eur Respir J 34 2009 888 894
6. G. Kovacs, R. Maier, and E. Aberer Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma Am J Respir Crit Care Med 180 2009 881 886
7. K. Hamada, S. Nagai, and S. Tanaka Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis Chest 131 2007 650 656
8. M.M. Hoeper The new definition of pulmonary hypertension Eur Respir J 34 2009 790 791
9. S. Bae, R. Saggar, and M.B. Bolster Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry Ann Rheum Dis 71 2012 1335 1342
10. R. Saggar, D. Khanna, and S. Shapiro Brief report: effect of ambrisentan treatment on exercise-induced pulmonary hypertension in systemic sclerosis: a prospective single-center, open-label pilot study Arthritis Rheum 64 2012 4072 4077
11. J.J. Tolle, A.B. Waxman, T.L. Van Horn, P.P. Pappagianopoulos, and D.M. Systrom Exercise-induced pulmonary arterial hypertension Circulation 118 2008 2183 2189
12. G. Kovacs, A. Olschewski, A. Berghold, and H. Olschewski Pulmonary vascular resistances during exercise in normal subjects: a systematic review Eur Respir J 39 2012 319 328
13. A.E. Frost, H.W. Farber, R.J. Barst, D.P. Miller, C.G. Elliott, and M.D. McGoon Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18 mm Hg: insights from the REVEAL registry Chest 143 2013 185 195
14. A. Prasad, J.L. Hastings, and S. Shibata Characterization of static and dynamic left ventricular diastolic function in patients with heart failure with a preserved ejection fraction Circ Heart Fail 3 2010 617 626
15. W.T. Abraham, P.B. Adamson, and R.C. Bourge Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial Lancet 377 2011 658 666
16. M.M. Hoeper, J.A. Barbera, and R.N. Channick Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension J Am Coll Cardiol 54 2009 S85 S96
17. S.D. Halpern, and D.B. Taichman Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure Chest 136 2009 37 43
18. C.A. Bush, J.M. Stang, C.F. Wooley, and J.W. Kilman Occult constrictive pericardial disease. Diagnosis by rapid volume expansion and correction by pericardiectomy Circulation 56 1977 924 930
19. I.M. Robbins, J.H. Newman, and R.F. Johnson Association of the metabolic syndrome with pulmonary venous hypertension Chest 136 2009 31 36
20. B.D. Fox, A. Shimony, and D. Langleben High prevalence of occult left heart disease in scleroderma-pulmonary hypertension Eur Respir J 42 2013 1083 1091
21. N. Fujimoto, B.A. Borlaug, and G.D. Lewis Hemodynamic responses to rapid saline loading: the impact of age, sex, and heart failure Circulation 127 2013 55 62
22. A. Holmgren, B. Jonsson, and T. Sjostrand Circulatory data in normal subjects at rest and during exercise in recumbent position, with special reference to the stroke volume at different work intensities Acta Physiol Scand 49 1960 343 363
23. S. Bevegard, A. Holmgren, and B. Jonsson Circulatory studies in well trained athletes at rest and during heavy exercise. With special reference to stroke volume and the influence of body position Acta Physiol Scand 57 1963 26 50
24. B.A. Borlaug, R.A. Nishimura, P. Sorajja, C.S. Lam, and M.M. Redfield Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction Circ Heart Fail 3 2010 588 595
25. W.D. Hager, I. Collins, and J.P. Tate Exercise during cardiac catheterization distinguishes between pulmonary and left ventricular causes of dyspnea in systemic sclerosis patients Clin Respir J 7 2013 227 236
26. M.M. Hoeper, S.H. Lee, and R. Voswinckel Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers J Am Coll Cardiol 48 2006 2546 2552
27. G. Kovacs, A. Avian, A. Olschewski, and H. Olschewski Zero reference level for right heart catheterization Eur Respir J 42 2013 1586 1594
28. M.M. Hoeper, R. Maier, and J. Tongers Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in pulmonary hypertension Am J Respir Crit Care Med 160 1999 535 541
29. D. Montani, L. Savale, and D. Natali Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension Eur Heart J 31 2010 1898 1907
30. O. Sitbon, M. Humbert, and X. Jais Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension Circulation 111 2005 3105 3111
31. S. Rich, E. Kaufmann, and P.S. Levy The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension N Engl J Med 327 1992 76 81
32. Z.C. Jing, X. Jiang, and Z.Y. Han Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension Eur Respir J 33 2009 1354 1360
33. A. Seferian, B. Helal, and X. Jais Ventilation/perfusion lung scan in pulmonary veno-occlusive disease Eur Respir J 40 2012 75 83
34. V. Cottin, J. Le Pavec, and G. Prevot Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome Eur Respir J 35 2010 105 111
35. V. Cottin, H. Nunes, and P.Y. Brillet Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity Eur Respir J 26 2005 586 593
36. P. Trip, E.J. Nossent, and F.S. de Man Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension - patient characteristics and treatment responses Eur Respir J 42 2013 1575 1585
37. M. Humbert, O. Sitbon, and A. Chaouat Pulmonary arterial hypertension in France: results from a national registry Am J Respir Crit Care Med 173 2006 1023 1030
38. L.M. Brown, H. Chen, and S. Halpern Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL registry Chest 140 2011 19 26
39. D.B. Badesch, G.E. Raskob, and C.G. Elliott Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry Chest 137 2010 376 387
40. J. Hurdman, R. Condliffe, and C.A. Elliot ASPIRE registry: Assessing the Spectrum of Pulmonary Hypertension Identified at a Referral Centre Eur Respir J 39 2012 945 955
41. M.M. Hoeper, D. Huscher, and H.A. Ghofrani Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry Int J Cardiol 168 2013 871 880
42. R.L. Benza, D.P. Miller, and M. Gomberg-Maitland Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) Circulation 122 2010 164 172
43. N. Nickel, H. Golpon, and M. Greer The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension Eur Respir J 39 2012 589 596
44. A.E. Frost, D.B. Badesch, and R.J. Barst The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US contemporary registries Chest 139 2011 128 137
45. Y. Ling, M.K. Johnson, and D.G. Kiely Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland Am J Respir Crit Care Med 186 2012 790 796
46. N. Galie, L. Rubin, and M. Hoeper Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial Lancet 371 2008 2093 2100
47. M. Germain, M. Eyries, and D. Montani Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension Nat Genet 45 2013 518 521
48. L. Ma, D. Roman-Campos, and E.D. Austin A novel channelopathy in pulmonary arterial hypertension N Engl J Med 369 2013 351 361
49. J.R. Thomson, R.D. Machado, and M.W. Pauciulo Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family J Med Genet 37 2000 741 745
50. R.D. Machado, M.A. Aldred, and V. James Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension Hum Mutat 27 2006 121 132
51. R.D. Machado, O. Eickelberg, and C.G. Elliott Genetics and genomics of pulmonary arterial hypertension J Am Coll Cardiol 54 2009 S32 S42
52. J.G. Coghlan, C.P. Denton, and E. Grunig Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study Ann Rheum Dis 2013 May 18 [E-pub ahead of print]
53. D. Khanna, H. Gladue, and R. Channick Recommendations for screening and detection of connective-tissue disease associated pulmonary arterial hypertension Arthritis Rheum 2013 Sep 10 [E-pub ahead of print]
54. H. Gladue, V. Steen, and Y. Allanore Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohorts J Rheumatol 40 2013 1706 1711